Podium Session: Non-Prostate GU Cancers
01/01/70 from 21:45 to 22:15
TBD
Lectures
-
POD-4 Patient trajectories of a real-world cohort initiating neoadjuvant chemotherapy for localized muscle-invasive bladder cancer: a population-based study analyzed by a multi-state modelling frameworkDr. Marian S. Wettstein, Canada
-
MP-16 Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: a role of CD163+ macrophages, B cells and PD-L1 immune checkpointDr. Kashif Visram, Canada
-
MP-17 Association between chronic urinary catheterization and bladder cancer incidence and mortality: A population-based studyDr. Amanda E Hird, Canada
-
MP-18 Assessment of the alignment between research funding allocation and consensus research priority areas in kidney cancerMr. Steven SL Lu, Canada
-
MP-19 Role of the upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinomaDr. Alice Dragomir, Canada
-
MP-20 Minimizing follow-up intensity of active surveillance for clinical stage 1 non-seminoma germ cell tumours (CS1 NSGCT): A 40-year experience at Princess Margaret Cancer CentreMr. Peter Gariscsak, Canada